In obese and/or Type II diabetic humans as well as dietary NAFLD rodent models, such CYP2E1 overexpression has been invariably linked to insulin resistance and the progression of NAFLD to NASH (non-alcoholic steatohepatitis) [10,12,13,14]. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.